Celyad Oncology SA Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/29/2024 | Q2 2024 | -$0.12 | $14,000 | |||
| 12/29/2023 | Q4 2023 | -$0.16 | $58,000 | |||
| 06/29/2023 | Q2 2023 | -$0.17 | $44,000 | |||
| 12/30/2022 | Q4 2022 | -$1.19 | $0 | |||
| 06/29/2022 | Q2 2022 | -$0.29 | $0 | |||
| 03/30/2022 | Q1 2022 | -$0.34 | $0 | |||
| 12/30/2021 | Q4 2021 | -$0.14 | $0 | |||
| 09/29/2021 | Q3 2021 | -$0.49 | $0 | |||
| 06/29/2021 | Q2 2021 | -$0.43 | $0 | |||
| 03/30/2021 | Q1 2021 | -$0.61 | $0 | |||
| 12/30/2020 | Q4 2020 | $0.35 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.39 | $0 | |||
| 06/29/2020 | Q2 2020 | -$1.19 | $5,000 | |||
| 12/30/2019 | Q4 2019 | -$0.95 | $6,000 | |||
| 06/29/2019 | Q2 2019 | -$1.34 | $1,500 | |||
| 03/30/2019 | Q1 2019 | -$0.57 | $1,500 | |||
| 12/31/2018 | Q4 2018 | -$1.59 | $597,000 | |||
| 06/29/2018 | Q2 2018 | -$1.79 | $2.52 M | |||
| 03/30/2018 | Q1 2018 | -$0.84 | $778,750 | |||
| 12/31/2017 | Q4 2017 | -$4.30 | $35,000 |
Celyad Oncology SA Earnings: Frequently Asked Questions
-
When is Celyad Oncology SA's earnings date?
Celyad Oncology SA has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 23rd, 2023 based off last year's report dates.
-
Did Celyad Oncology SA beat their earnings estimates last quarter?
In the previous quarter, Celyad Oncology SA (:CYAD) reported $-0.61 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.17 by $0.56.
-
How can I listen to Celyad Oncology SA's earnings conference call?
The conference call for Celyad Oncology SA's latest earnings report can be listened to online.
-
How can I read Celyad Oncology SA's conference call transcript?
The conference call transcript for Celyad Oncology SA's latest earnings report can be read online.
-
How much revenue does Celyad Oncology SA generate each year?
Celyad Oncology SA (:CYAD) has a recorded annual revenue of $102,000.
-
How much profit does Celyad Oncology SA generate each year?
Celyad Oncology SA (:CYAD) has a recorded net income of $102,000. Celyad Oncology SA has generated $-0.33 earnings per share over the last four quarters.
-
What is Celyad Oncology SA's price-to-earnings ratio?
Celyad Oncology SA (:CYAD) has a price-to-earnings ratio of -2.16 and price/earnings-to-growth ratio is -0.02.
